Price (delayed)
$2.43
Market cap
$181.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.42
Enterprise value
-$51.6M
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides
There are no recent dividends present for OSUR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.